Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Progressive multifocal leukoencephalopathy in a 16-year-old patient with pancytopenia after autologous bone marrow transplantation for relapsed Hodgkin lymphoma.

Fukuoka K, Kaneko T, Akiyama M.

Pediatr Blood Cancer. 2011 Mar;56(3):507-8. doi: 10.1002/pbc.22819. No abstract available.

PMID:
21154950
2.

Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy.

Re D, Bamborschke S, Feiden W, Schröder R, Lehrke R, Diehl V, Tesch H.

Bone Marrow Transplant. 1999 Feb;23(3):295-8. Review.

3.

Allogeneic marrow transplantation for myelodysplastic syndrome complicating autologous bone marrow transplantation.

Bashir S, Cook P, Katz M, Mittelman A, Ahmed T.

Cancer Invest. 1994;12(5):484-7.

PMID:
7922704
4.

Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5).

Coppo P, Laporte JP, Aoudjhane M, Lebon P, Isnard F, Lesage S, Gorin NC, Najman A.

Bone Marrow Transplant. 1999 Feb;23(4):401-3.

5.

Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia.

Kesari S, Akar S, Saad A, Drappatz J, Koralnik IJ, DeAngelo DJ.

J Clin Oncol. 2008 Aug 1;26(22):3804-7. doi: 10.1200/JCO.2008.17.3047. No abstract available.

PMID:
18669471
6.

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy.

Buckanovich RJ, Liu G, Stricker C, Luger SM, Stadtmauer EA, Schuster SJ, Duffy K, Tsai D, Pruitt A, Porter DL.

Ann Hematol. 2002 Jul;81(7):410-3. Epub 2002 Jul 12.

PMID:
12185517
7.

Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2.

Przepiorka D, Jaeckle KA, Birdwell RR, Fuller GN, Kumar AJ, Huh YO, McCutcheon I.

Bone Marrow Transplant. 1997 Dec;20(11):983-7.

8.

Fatal eosinophilic disease following autologous bone marrow transplantation.

Gross TG, Hoge FJ, Jackson JD, Sammut PH, Warkentin PI.

Bone Marrow Transplant. 1994 Aug;14(2):333-7.

PMID:
7994253
9.

Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantation.

Cuzzola M, Irrera G, Iacopino O, Cuzzocrea A, Messina G, Console G, Iacopino P, Morabito F.

Clin Infect Dis. 2003 Oct 1;37(7):e102-6. Epub 2003 Sep 5.

PMID:
13130419
10.

High-dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease.

Lim SH, Baglin TP, Flavell DJ, Flavell SU, Wimperis JZ, Marcus RE.

Eur J Haematol. 1992 Feb;48(2):110-4.

PMID:
1547872
11.

Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.

Brice P, Gisselbrecht C, Ferme C, Lepage E, Baruchel A, Marolleau JP, Gerota O, Boiron M.

Nouv Rev Fr Hematol. 1991;33(3):267-72.

PMID:
1956765
12.

High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's disease.

Harding M, Selby P, Gore M, Perren T, Treleavan J, Mansi J, Zulian G, Milan S, Meldrum M, Viner C, et al.

Eur J Cancer. 1992;28A(8-9):1396-400.

PMID:
1515256
13.

Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia.

Seong D, Bruner JM, Lee KH, Mirza N, Kwon BD, Lee JH, Lee YY, Ro J, Talpaz M, Champlin R, Deisseroth AB.

Clin Infect Dis. 1996 Aug;23(2):402-3. No abstract available.

PMID:
8842290
14.

Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.

Dann EJ, Daugherty CK, Larson RA.

Bone Marrow Transplant. 1997 Sep;20(5):369-74.

15.

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial.

Stiff PJ, Unger JM, Forman SJ, McCall AR, LeBlanc M, Nademanee AP, Bolwell BJ, Fisher RI; Southwest Oncology Group..

Biol Blood Marrow Transplant. 2003 Aug;9(8):529-39.

16.

Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for acute myeloid leukemia.

Lee HC, Mulanovich V, Nieto Y.

J Natl Compr Canc Netw. 2014 Dec;12(12):1660-4; quiz 1664.

PMID:
25505206
17.

Reversible leukoencephalopathy associated with graft-versus-host disease: MR findings.

Provenzale JM, Graham ML.

AJNR Am J Neuroradiol. 1996 Aug;17(7):1290-4.

18.
19.

Cerebral Hodgkin's disease and progressive multifocal leucoencephalopathy.

Williamson PJ, Allan NC, McIntyre MA.

Clin Lab Haematol. 1989;11(3):281-5. No abstract available.

PMID:
2591160
20.

Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.

Kahn ST, Flowers CR, Lechowicz MJ, Hollenbach K, Johnstone PA.

Cancer J. 2005 Sep-Oct;11(5):425-31.

PMID:
16259874

Supplemental Content

Support Center